AG

:   anesthetized group

BP

:   blood pressure

DAP

:   diastolic arterial pressure

HR

:   heart rate

IBP

:   invasive blood pressure

MAP

:   mean arterial pressure

NIBP

:   noninvasive blood pressure

R

:   Pearson correlation coefficient

SAP

:   systolic arterial pressure

SG

:   standing group

Arterial blood pressure (BP) is defined as the product of cardiac output and systemic vascular resistance. While cardiac output is a better marker of flow and perfusion, its measurement is cumbersome in many clinical situations. Arterial BP measurements are a good alternative to learn about potential flow and tissue perfusion.[1](#jvim13928-bib-0001){ref-type="ref"}, [2](#jvim13928-bib-0002){ref-type="ref"} Direct techniques require cannulation of an artery, which can be impractical, labor intensive, time‐consuming and even impossible in certain settings. Noninvasive oscillometric blood pressure readings (NIBP) are easily obtained and measure changes in oscillations in the sphygmomanometer cuff pressure induced by alterations in blood flow due to deflation of a cuff placed around an artery. The maximal oscillations are used to determine mean arterial pressure (MAP) and different algorithms estimate systolic (SAP) and diastolic (DAP) BP.[2](#jvim13928-bib-0002){ref-type="ref"}

The potential applications of BP measurements in standing horses encompass the evaluation and monitoring of renal disease, cardiac disease, severe or chronic pain, fluid resuscitation monitoring and is well established in small animals and human medicine. BP monitoring in horses is more commonly used to recognize hypotension and is useful in guiding and monitoring treatment in events such as: hypovolemia, acute hemorrhage, systemic inflammatory response syndrome, sepsis, anaphylaxis, heart failure, or aortic valve disease.[2](#jvim13928-bib-0002){ref-type="ref"}, [3](#jvim13928-bib-0003){ref-type="ref"} Hypertension is uncommonly recognized in horses but can occur in any cases of acute of chronic pain, laminitis, Equine Metabolic Syndrome and renal failure.[2](#jvim13928-bib-0002){ref-type="ref"}, [4](#jvim13928-bib-0004){ref-type="ref"}, [5](#jvim13928-bib-0005){ref-type="ref"}, [6](#jvim13928-bib-0006){ref-type="ref"} Four studies have demonstrated good agreement between oscillometric NIBP and invasive blood pressure (IBP) in foals and anesthetized adult horses.[7](#jvim13928-bib-0007){ref-type="ref"}, [8](#jvim13928-bib-0008){ref-type="ref"}, [9](#jvim13928-bib-0009){ref-type="ref"}, [10](#jvim13928-bib-0010){ref-type="ref"} However, ambiguous findings have been reported in studies assessing the accuracy of different oscillometric BP devices in the standing adult horse.[1](#jvim13928-note-0001){ref-type="fn"} ^,^ [2](#jvim13928-note-0002){ref-type="fn"} The importance for validation of devices in the species of interest and under circumstances in which the patient is being tested has been emphasized.[11](#jvim13928-bib-0011){ref-type="ref"} To the authors\' knowledge, the accuracy of NIBP in adult standing horses in hypo‐ and hypertensive ranges has not been evaluated. The aims of this study were to investigate the agreement of oscillometric NIBP measurements and IBP measurements in different BP ranges in the standing horse and compare it to horses under general anesthesia.

Methods {#jvim13928-sec-0008}
=======

The study was performed with the approval and supervision of the appropriate committee for animal care and experimentation. The study population consisted of a standing research group (SG) and a group of client‐owned horses presented to the University Teaching Hospital for surgical procedures under general anesthesia (AG). The SG was composed of 8 Warmblood mares 11.6 ± 1.5 years old and weighing 568 ± 62 kg. The AG consisted of 6 geldings and 2 mares (1 Icelandic horse, 1 Pony and 6 Warmbloods) 10.8 ± 7.6 years old and weighing 481.8 ± 89.1 kg.

The mares from the SG were placed in the stalls at least 15 minutes before being instrumented and a general physical examination was performed. A 13G indwelling catheter was placed in a jugular vein using standard aseptic technique and all drugs were administered through this catheter. Horses were equipped with a digital telemetry unit[3](#jvim13928-note-0003){ref-type="fn"} following manufacturer\'s instructions.

An oscillometric monitor,[4](#jvim13928-note-0004){ref-type="fn"} with a cuff bladder width to tail girth ratio of 0.4--0.6 (manufacturer\'s recommendations), was centered over the coccygeal artery around the base of the unclipped tail and used for NIBP measurements. To correct readings to the level of the heart base, the vertical distance between the base of the heart, as estimated by the point of the shoulder, and the base of the tail was measured and a correction factor of 0.77 mmHg/cm was applied.[12](#jvim13928-bib-0012){ref-type="ref"}

Noninvasive blood pressure was measured eight times. When pulse rate obtained by the oscillometric device differed by more than twenty percent of the heart rate (HR) obtained electrocardiographically,[13](#jvim13928-bib-0013){ref-type="ref"} the value was excluded. As recommended by ACVIM guidelines for device validation in small animals, the first measurement was discarded and the average of three to seven consecutive readings was calculated.[11](#jvim13928-bib-0011){ref-type="ref"}

For IBP monitoring, a 20 or 22G over the needle catheter was placed in the facial or transversal facial artery, after aseptic preparation, and secured with cyanoacrylate glue and tape. The catheter was connected via nondistensible heparin‐saline filled tubing to a disposable BP transducer, which was positioned and zeroed to the level of the heart base and connected to a monitor.[5](#jvim13928-note-0005){ref-type="fn"} Catheter placement was attempted in the unsedated horse and if necessary, xylazine[6](#jvim13928-note-0006){ref-type="fn"} 0.5 mg/kg IV was administered. BP recordings were performed a minimum of 30 minutes after xylazine administration.

Paired readings of invasive and noninvasive SAP, DAP and MAP were obtained simultaneously, with IBP readings taken at the end of the deflation cycle of the noninvasive blood pressure monitor. Hypertension was induced with an IV phenylephrine[7](#jvim13928-note-0007){ref-type="fn"} infusion (3 μg/kg/min diluted in 1 L 0.9% NaCl solution over 15 minutes) and hypotension with IV acepromazine[8](#jvim13928-note-0008){ref-type="fn"} (0.05 mg/kg).

Blood pressure was obtained at four different time points: before pharmacological intervention, immediately after phenylephrine infusion, 35 minutes after phenylephrine infusion, and 30 minutes after acepromazine. Time points were chosen based on previously described temporal effects of acepromazine and phenylephrine to detect maximal changes in BP.[14](#jvim13928-bib-0014){ref-type="ref"}, [15](#jvim13928-bib-0015){ref-type="ref"}, [16](#jvim13928-bib-0016){ref-type="ref"}

Noninvasive blood pressure was obtained and corrected in the AG using the same device and protocol described above. Horses received anesthetic protocols adjusted individually to the needs of the horse and surgical procedure (Supporting Information). Only recordings from surgeries performed in dorsal recumbency were used. Three BP ranges were defined for the AG as: hypotension (MAP \< 65 mmHg), normotension (MAP = 65--90 mmHg), and hypertension (MAP \> 90 mmHg). Anesthetic procedures were not modified for the study. If necessary, dobutamine[9](#jvim13928-note-0009){ref-type="fn"} was administered intraoperatively targeting a MAP of 70 mmHg (Table S1).

Statistical Analysis {#jvim13928-sec-0009}
--------------------

A Shapiro--Wilk Test was used to evaluate normality. Pearson correlation coefficient (*R*) was calculated to assess the correlation between NIBP and IBP for each phase (normo‐, hypo‐ and hypertensive) separately and for all phases together. Agreement between NIBP and IBP was quantified using the Bland and Altman method for repeated measurements.[17](#jvim13928-bib-0017){ref-type="ref"} The bias was reported as the mean difference between NIBP and IBP. A positive bias reflected underestimation and a negative bias reflected overestimation of IBP by NIBP. The limits of agreement were calculated as bias ± (1.96 × standard deviation of the bias). A paired sample *t*‐test was used to determine significant differences between measurements at different time points in the SG and AG. All analyses were done with a commercial statistical software[10](#jvim13928-note-0010){ref-type="fn"} and significance was set at *P* \< .05.

Results {#jvim13928-sec-0010}
=======

The SG had normal general physical examinations and no complications during or after completing the protocol. All horses in the SG showed frequent second degree atrioventricular and/or sinus block/arrest after phenylephrine. Three mares in the SG developed reflex tachycardia after acepromazine.

A total of 148 and 124 sets of paired NIBP and IBP measurements were obtained in the SG and AG, respectively. The cuff width to tail circumference ratio was 0.47 ± 0.03 and 0.49 ± 0.05, and the vertical distance was 26.0 ± 3.0 and 24.1 ± 6.0 in the SG and the AG, respectively. One SG mare was sedated for catheter placement. One mare in the SG had no pulse rates within 20% of the HR obtained electrocardiographically after phenylephrine and this data point was excluded from analysis. One intra‐arterial catheter was lost before IBP after acepromazine could be obtained. The AG data were collected for the interval below 65 mmHg in 6/8 horses, between 65--90 mmHg in 8/8 horses and above 90 mmHg in 6/8 horses. A summary of IBP and NIBP in standing and anesthetized horses is shown in Table [1](#jvim13928-tbl-0001){ref-type="table-wrap"}.

###### 

Summary of invasive blood pressure (IBP) and noninvasive blood pressure (NIBP) and heart rate (HR) in standing and anesthetized horses

                               SYS (mmHg)                                             DIA (mmHg)                                                                                                    MEAN (mmHg)                                            HR (bpm)                                                                                                                                                                                                                                                                           
  ---------------------------- ------------------------------------------------------ ------------------------------------------------------------------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------------------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------------------------------------------------------------- ----------------------------------------------------
  Standing group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Hypotensive Phase (n = 7)    119.5 ± 9.3[a](#jvim13928-note-0102){ref-type="fn"}    103.6 ± 8.7[a](#jvim13928-note-0102){ref-type="fn"} (83.3 ± 7.2[a](#jvim13928-note-0102){ref-type="fn"})      73.9 ± 7.9[a](#jvim13928-note-0102){ref-type="fn"}     65.5 ± 10.0[a](#jvim13928-note-0102){ref-type="fn"} (45.2 ± 7.8[a](#jvim13928-note-0102){ref-type="fn"})      89.1 ± 6.8[a](#jvim13928-note-0102){ref-type="fn"}     78.6 ± 9.7[a](#jvim13928-note-0102){ref-type="fn"} (58.2 ± 7.7[a](#jvim13928-note-0102){ref-type="fn"})       45.5 ± 9.5[a](#jvim13928-note-0102){ref-type="fn"}
  Normotensive Phase (n = 8)   169.0 ± 24.6                                           142.3 ± 20.5 (122.2 ± 20.4)                                                                                   110.4 ± 16.3                                           100.2 ± 17.9 (80.2 ± 17.4)                                                                                    131.5 ± 18                                             116.2 ± 19.4 (96.2 ± 19.1)                                                                                    34.0 ± 4.2
  Hypertensive Phase (n = 7)   236.7 ± 17.9[a](#jvim13928-note-0102){ref-type="fn"}   179.6 ± 35.6[a](#jvim13928-note-0102){ref-type="fn"} (159.5 ± 33.4[a](#jvim13928-note-0102){ref-type="fn"})   148.2 ± 15.6[a](#jvim13928-note-0102){ref-type="fn"}   141.4 ± 28.5[a](#jvim13928-note-0102){ref-type="fn"} (121.3 ± 26.6[a](#jvim13928-note-0102){ref-type="fn"})   180.7 ± 11.9[a](#jvim13928-note-0102){ref-type="fn"}   155.7 ± 30.0[a](#jvim13928-note-0102){ref-type="fn"} (135.6 ± 28.0[a](#jvim13928-note-0102){ref-type="fn"})   35.5 ± 4.6
  Anesthetized group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Hypotensive Phase (n = 6)    82.4 ± 7.8[a](#jvim13928-note-0102){ref-type="fn"}     79.3 ± 8.6[a](#jvim13928-note-0102){ref-type="fn"} (97.7 ± 8.0[a](#jvim13928-note-0102){ref-type="fn"})       43.0 ± 3.1[a](#jvim13928-note-0102){ref-type="fn"}     40.8 ± 10.0[a](#jvim13928-note-0102){ref-type="fn"} (59.2 ± 9.1[a](#jvim13928-note-0102){ref-type="fn"})      57.1 ± 4.7[a](#jvim13928-note-0102){ref-type="fn"}     54.9 ± 10.6[a](#jvim13928-note-0102){ref-type="fn"} (73.2 ± 10.0)                                             35.9 ± 3.1
  Normotensive Phase (n = 8)   106.6 ± 8.5                                            103.3 ± 10.8 (121.9 ± 10.6)                                                                                   59.7 ± 5.3                                             59.6 ± 10.1 (78.2 ± 9.7)                                                                                      76.1 ± 5.0                                             75.7 ± 8.6 (94.3 ± 8.6)                                                                                       30.3 ± 4.1
  Hypertensive Phase(n = 6)    125.5 ± 14.1[a](#jvim13928-note-0102){ref-type="fn"}   122.0 ± 20.8 (139.5 ± 18.8)                                                                                   75.8 ± 5.2[a](#jvim13928-note-0102){ref-type="fn"}     76.0 ± 17.0[a](#jvim13928-note-0102){ref-type="fn"} (93.5 ± 15.1[a](#jvim13928-note-0102){ref-type="fn"})     93.2 ± 3.1[a](#jvim13928-note-0102){ref-type="fn"}     94.5 ± 17.4[a](#jvim13928-note-0102){ref-type="fn"} (111.9 ± 15.4[a](#jvim13928-note-0102){ref-type="fn"})    32.6 ± 3.4

SYS, systolic; DIA, diastolic. NIBP values in brackets = noncorrected measurements.

Significant difference compared to normotensive phase.

John Wiley & Sons, Ltd

The mean bias, lower and upper limit of agreement, and R are listed in Table [2](#jvim13928-tbl-0002){ref-type="table-wrap"}. Scatter and Bland and Altman plots for mean BP are shown in Figures [1](#jvim13928-fig-0001){ref-type="fig"} and [2](#jvim13928-fig-0002){ref-type="fig"}. When phases were studied separately, significant correlations were detected for the normotensive phase in the SG and the SAP of the normo‐ and hypertensive phase in the AG (Table [2](#jvim13928-tbl-0002){ref-type="table-wrap"}). Validation criteria recommended by the ACVIM for small animals was only met for SAP in anesthetized horses. The MAP in anesthetized horses met all criteria aside from a lower than recommended R (Table [3](#jvim13928-tbl-0003){ref-type="table-wrap"}).

###### 

Results of Bland and Altman analysis and correlation between invasive and noninvasive blood pressure for the standing and the anesthetized group

                                                    Bias (mmHg)   LLA (mmHg)   ULA (mmHg)   *R*     *P*
  ------------------------------------------------- ------------- ------------ ------------ ------- ---------
  Standing group: all phases combined (n = 8)                                                       
  Systolic BP                                       30.0          −18.8        78.7         0.84    \<0.001
  Diastolic BP                                      8.9           −25.5        43.3         0.84    \<0.001
  Mean BP                                           16.4          −16.1        48.9         0.88    \<0.001
  Standing group: hypotensive phase (n = 7)                                                         
  Systolic BP                                       15.9          −0.4         32.2         0.58    0.18
  Diastolic BP                                      8.4           −9.8         26.6         0.45    0.31
  Mean BP                                           10.5          −5.1         26.1         0.58    0.17
  Standing group: normotensive phase (n = 8)                                                        
  Systolic BP                                       26.8          −2.1         51.4         0.85    0.01
  Diastolic BP                                      10.2          −15.3        35.6         0.72    0.05
  Mean BP                                           15.3          −9.6         40.1         0.78    0.02
  Standing group: hypertensive phase (n = 7)                                                        
  Systolic BP                                       57.2          −10.9        125.3        0.30    0.51
  Diastolic BP                                      6.8           −54.1        67.6         0.10    0.83
  Mean BP                                           25.0          −29.8        79.7         0.37    0.42
  Anesthetized group: all phases combined (n = 8)                                                   
  Systolic BP                                       3.3           −13.3        19.8         0.92    \<0.001
  Diastolic BP                                      0.6           −22.8        24.0         0.76    \<0.001
  Mean BP                                           0.5           −22.3        23.2         0.81    \<0.001
  Anesthetized group: \<65 mmHg phase (n = 6)                                                       
  Systolic BP                                       3.0           −11.6        17.6         0.59    0.22
  Diastolic BP                                      2.1           −16.7        21.0         0.26    0.61
  Mean BP                                           2.3           −17.8        22.4         0.28    0.59
  Anesthetized group: 65--90 mmHg phase (n = 8)                                                     
  Systolic BP                                       3.3           −9.8         16.4         0.79    0.02
  Diastolic BP                                      0.0           −24.1        24.2         −0.20   0.64
  Mean BP                                           0.4           −20.6        21.3         −0.18   0.67
  Anesthetized group: \>90 mmHg phase (n = 6)                                                       
  Systolic BP                                       3.5           −20.8        27.8         0.81    0.05
  Diastolic BP                                      −0.2          −30.2        29.8         0.46    0.35
  Mean BP                                           −1.2          −31.5        29.0         0.68    0.14

LLA, Lower limit of agreement; ULA, upper limit of agreement; P, probability level; R, Pearson correlation coefficient.

John Wiley & Sons, Ltd

![Mean noninvasive blood pressure (NIBP) values plotted against the invasive blood pressure (IBP) (n = 8) in the standing horse (**A**) and under general anesthesia (GA) (**B**). The solid line represents the regression line, the dotted line the 45° line and the filled area the confidence band.](JVIM-30-866-g001){#jvim13928-fig-0001}

![Bland and Altman plot of mean arterial blood pressure (BP) (n = 8) in the standing horse (**A**) and under general anesthesia (GA) (**B**). Noninvasive blood pressure= NIBP, Invasive blood pressure= IBP. Mean bias (solid line) and Lower and upper limits of agreement (dotted line) are indicated.](JVIM-30-866-g002){#jvim13928-fig-0002}

###### 

Adherence to the validation criteria for blood pressure devices recommended by ACVIM consensus statement establishing the "Guidelines for the Identification, Evaluation, and Management of Systemic Hypertension in Dogs and Cats"

                                                Standing Group (n = 8)   Anesthetized Group (n = 8)   ACVIM Criteria                                             
  --------------------------------------------- ------------------------ ---------------------------- ---------------- ------------- ------------- ------------- -------
  Mean Difference of paired readings (mmHg)     30.0                     [8.9]{.ul}                   16.4             [3.3]{.ul}    [0.6]{.ul}    [0.5]{.ul}    ≤ ±10
  Standard Deviation of the difference (mmHg)   24.9                     17.5                         16.6             [8.5]{.ul}    [12.0]{.ul}   [11.6]{.ul}   ≤ 15
  Correlations (*R*) between paired pressures   0.84                     0.84                         0.88             [0.92]{.ul}   0.76          0.81          ≥0.9
  Within 10 mmHg of IBP (%)                     17                       [52]{.ul}                    31               [80]{.ul}     [70]{.ul}     [55]{.ul}     ≥50
  Within 20 mmHg of IBP (%)                     34                       79                           72               [95]{.ul}     [90]{.ul}     [95]{.ul}     ≥80

IBP, invasive blood pressure; SYS, Systolic blood pressure; DIA, diastolic blood pressure; MEAN, mean blood pressure.

Underlined values meet validation criteria.

John Wiley & Sons, Ltd

Discussion {#jvim13928-sec-0011}
==========

Noninvasive blood pressure was strongly correlated with IBP and reliably differentiated increases and decreases in BP in the SG and AG. However, in standing horses the NIBP underestimated IBP and the accuracy and precision were low, indicated by the large bias and wide limits of agreement, respectively.

Several studies have investigated the agreement of NIBP and IBP monitors in horses (Table S2). Different study designs, including different age, size, position, consciousness, correction factors, devices, and arteries used, make direct comparison difficult. Similar to previous findings,[9](#jvim13928-bib-0009){ref-type="ref"} the overall agreement in our study was higher in anesthetized animals. This could be because of factors such as motion, muscle tone and anxiety causing erroneous detection of pressure waveforms. Previous studies suggested that more accurate NIBP measurements could be obtained in neonates,[7](#jvim13928-bib-0007){ref-type="ref"}, [9](#jvim13928-bib-0009){ref-type="ref"} however, in the study presented here performance of the oscillometric device in the AG was similar to previous studies in foals. Compared to other studies in adult horses under general anesthesia, the device used in this study showed better accuracy and similar or better precision.[8](#jvim13928-bib-0008){ref-type="ref"}, [18](#jvim13928-bib-0018){ref-type="ref"} Results in standing horses[1](#jvim13928-note-0001){ref-type="fn"} ^,^ [2](#jvim13928-note-0002){ref-type="fn"} vary more between studies. Explanations for discrepancies include one or more of: the use of different devices, horses\' compliance and different BP ranges.

Mean arterial pressure is a better marker of potential flow than SAP or DAP and is minimally affected by amplifications of pressure waveform in peripheral vessels.[2](#jvim13928-bib-0002){ref-type="ref"}, [19](#jvim13928-bib-0019){ref-type="ref"} The maximum oscillation amplitude, representing MAP, is more accurately detected by oscillometric monitors than the algorithm‐dependent SAP and DAP,[20](#jvim13928-bib-0020){ref-type="ref"}, [21](#jvim13928-bib-0021){ref-type="ref"} which is why some previous studies only report MAP.[7](#jvim13928-bib-0007){ref-type="ref"}, [22](#jvim13928-bib-0022){ref-type="ref"} We chose to report all three variables, as one of our aims was device evaluation.[11](#jvim13928-bib-0011){ref-type="ref"} Interestingly in the AG, while the bias was slightly larger than for MAP (3 versus 0.5 mmHg), the best accuracy, precision and fulfillment ACVIM criteria were seen in SAP. Validation criteria for small animals were based on challenges when acquiring standardized readings, current literature on indirect devices and intervention points for treatment in these species.[11](#jvim13928-bib-0011){ref-type="ref"} The fact that guidelines were only met for the systolic NIBP in the AG in this study should be interpreted with caution as requirements for horses have not been formally established.

Although direct techniques measure the pressure within a vessel, indirect methods use cuff pressure to estimate arterial pressure.[23](#jvim13928-bib-0023){ref-type="ref"} Therefore, changes in the physical properties of the arterial wall mainly affect indirect methods. Both phenylephrine and acepromazine have antagonistic effects on postsynaptic alpha‐adrenergic receptors, acting on smooth muscle of vasculature, inducing vasoconstriction and vasodilation, respectively.[24](#jvim13928-bib-0024){ref-type="ref"}, [25](#jvim13928-bib-0025){ref-type="ref"} This alters the viscoelastic properties of the artery, possibly causing larger discrepancies seen during hypo‐ and hypertension.[26](#jvim13928-bib-0026){ref-type="ref"}

Controversies exist about the influence of different pressure states on the accuracy of the oscillometric BP in horses and other species. Some reports show negative effects of hypotension on the accuracy of NIBP in horses,[27](#jvim13928-bib-0027){ref-type="ref"} cats[28](#jvim13928-bib-0028){ref-type="ref"} and dogs,[29](#jvim13928-bib-0029){ref-type="ref"} whereas other reports in adult horses[30](#jvim13928-bib-0030){ref-type="ref"} and foals found no effect.[9](#jvim13928-bib-0009){ref-type="ref"} Previous studies reported no effects when pressure was modulated by anesthetic depth and administration of dobutamine and phenylephrine in anesthetized foals.[7](#jvim13928-bib-0007){ref-type="ref"} In contrast, a recent report on anesthetized adult horses inducing hypertension with dobutamine and norepinephrine and hypotension with isoflurane and nitroglycerine, found poor agreement between IBP and NIBP in hypo‐ and hypertensive ranges.[18](#jvim13928-bib-0018){ref-type="ref"} In anesthetized small animals, measurements during phenylephrine‐induced hypertension were accurate,[31](#jvim13928-bib-0031){ref-type="ref"} although an increase in bias was shown with higher pressure ranges in another study.[32](#jvim13928-bib-0032){ref-type="ref"} In clinical practice, inotropes and vasopressors are used frequently in hemodynamically compromised animals. The differences between measurements in naturally occurring and pharmacologically induced hypo‐ or hypertension deserve attention.

The effect of gravity and the large vertical distance between the coccygeal artery and the base of the heart in horses results in underestimation of BP when this is measured in the coccygeal artery with the equine standing and overestimation of BP using the same location with a horse in dorsal recumbency. Measurement results should therefore be corrected to heart level or described as "uncorrected" values.[33](#jvim13928-bib-0033){ref-type="ref"} Although a correction factor of 0.77 mmHg/cm of vertical distance between the base of the tail and the point of the shoulder[12](#jvim13928-bib-0012){ref-type="ref"} was added or subtracted in standing or dorsally recumbent horses, respectively, most corrected NIBP readings underestimated IBP readings in the standing group in this study. This correction factor is physiologically derived and has been validated in humans.[34](#jvim13928-bib-0034){ref-type="ref"} The factor has been described and traditionally used in horses.[12](#jvim13928-bib-0012){ref-type="ref"} The evaluation of different correction factors would be interesting but is beyond the scope of this experiment.

The use of cuff width to tail circumference ratios from 0.2 to 0.9[2](#jvim13928-bib-0002){ref-type="ref"}, [7](#jvim13928-bib-0007){ref-type="ref"}, [9](#jvim13928-bib-0009){ref-type="ref"}, [13](#jvim13928-bib-0013){ref-type="ref"} have been described, Cuffs that are too wide will cause underestimation and cuffs that are too small cause overestimation of NIBP.[2](#jvim13928-bib-0002){ref-type="ref"}, [13](#jvim13928-bib-0013){ref-type="ref"}, [33](#jvim13928-bib-0033){ref-type="ref"} Arguably, smaller ratios could have reduced the bias in this study similarly to the report in anesthetized horses.[22](#jvim13928-bib-0022){ref-type="ref"} In a recent study, a reduction in the mean difference between IBP and NIBP measurements from 9.91 to 0.39 mmHg was seen with a change in cuff width to appendage circumference ratio from 0.42 to 0.25 in horses placed in lateral recumbency using a similar oscillometric monitor. Interestingly, the mean bias in the AG we report, where a cuff width to tail circumference ratio of 0.49 ± 0.05 was used, was 0.5 mmHg, similar to the lowest mean difference reported in the mentioned study,[22](#jvim13928-bib-0022){ref-type="ref"} making it uncertain if a different cuff size would improve the accuracy of NIBP measurements.

Incompatibilities between changes in pulse wave forms and the applied algorithm induced by changes in HR and rhythm might be another explanation for the low accuracy and precision. It has been reported that the rate of the cuff deflation to the HR can be a source of error, if the deflation rate is too rapid or the HR is too slow.[35](#jvim13928-bib-0035){ref-type="ref"} It has been shown that changes in HR cause a significant alteration in the shape of the plateau of the oscillometric curve, which particularly affects the MAP.[26](#jvim13928-bib-0026){ref-type="ref"} In our study, all of the horses developed frequent second degree atrioventricular, sinus block/arrest, or both after phenylephrine and reflex tachycardia was seen in 3 mares in the SG after acepromazine administration, which represents a plausible source of inaccuracy. Moreover, phenylephrine modulates the pulse wave contour and impedance in distally located vessels, which might interfere with the device\'s accuracy.[31](#jvim13928-bib-0031){ref-type="ref"}

Limitations of this study include the use of a different peripheral artery for IBP and NIBP. Pressures vary between arteries because of reflections of the forward propagating pressure pulse wave, leading to amplification of the SAP[27](#jvim13928-bib-0027){ref-type="ref"} and slight dampening of the DAP in distally located vessels, whereas the MAP stays fairly unaffected.[19](#jvim13928-bib-0019){ref-type="ref"} The aortic root might be considered the gold standard for IBP measurements. Central BP can be assessed in the common carotid artery, as a surrogate for the aortic pressures[19](#jvim13928-bib-0019){ref-type="ref"} and a recent report in anesthetized horses showed good agreement in blood pressure measurements between the facial and the carotid artery,[10](#jvim13928-bib-0010){ref-type="ref"} making the facial artery appropriate for our aims. Another limitation of the study is the limited sample size and the homogeneity of size and breed within the study population. It is therefore true that making extrapolations for the entire equine population could be difficult, yet the sample is representative of horses of average size and weight. The choice of sample size was based on the ACVIM guidelines that recommended a minimum of 8 animals when intra‐arterial methods are used for comparison.[11](#jvim13928-bib-0011){ref-type="ref"}

While the evaluated device allows an estimation of BP and adequate differentiation of trends in pressure, the device\'s accuracy and precision was limited in standing horses compared to those under general anesthesia. Observations in larger populations, in nonpharmacologically induced, naturally occurring hyper‐ and hypotensive horses, and studies with different pharmacologic interventions could help to further evaluate the source of the inaccuracy and define factors to be taken into account when interpreting NIBP measurement in compromised, standing horses.

Supporting information
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**Table S1.** Summary of anesthetic protocol and procedures used in the 8 horses in the anesthetized group.
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Click here for additional data file.

###### 

**Table S2.** Comparison of recent studies evaluating oscillometric blood pressure monitors.
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Click here for additional data file.
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